RESEARCH USE ONLY — Not for human or animal consumption. | Order before 2PM CST for Same-Day Dispatch
Cagrilintide + SM Blend 10mg
Cagrilintide + SM Blend is a 10mg metabolic research peptide combination containing 5mg amylin analog and 5mg GLP-1 receptor agonist. Studied for appetite signaling, GLP-1 receptor pathways, amylin receptor modulation, glycemic control, and weight management models. Third-party HPLC tested by a US lab. Lyophilized powder. Ships from Texas.
$89.99
You save
99%+ HPLC Purity
3rd Party Verified
QR-Verified COAs
Scan & Verify
Next-Day Ship
Free US Shipping
Same-Day Dispatch
Before 2PM CST
Cagrilintide + SM Blend 10mg
Cagrilintide + SM Blend is a research peptide combination containing 5mg amylin analog and 5mg GLP-1 receptor agonist for studies on metabolic regulation, appetite signaling, GLP-1 receptor pathways, amylin receptor modulation, glycemic control, and weight management models. Third-party HPLC tested by BioRegen Labs. Lyophilized powder, 10mg total vial.
Research Mechanism
Cagrilintide (5mg) — Long-acting amylin and calcitonin receptor agonist (DACRA). Studied for amylin receptor agonism, appetite regulation, delayed gastric emptying, satiety signaling, and post-meal glucose control in laboratory models.
SM (5mg) — GLP-1 receptor agonist. Researched for metabolic effects, insulin secretion, gastric emptying, glycemic control, and appetite suppression in research settings.
Research Applications
- Cagrilintide SM combination studies
- Metabolic regulation and glycemic control research
- Appetite signaling and satiety pathway studies
- GLP-1 and amylin receptor combination assays
- Weight management models
- Postprandial glucose and insulin secretion studies
- Amylin incretin synergy research
- FREE US SHIPPING
Secure payment options
- Bank-grade encryption
- SSL Secure
- Wrong Product? We Reship
- Discreet Shipping
About Cagrilintide + SM Research Peptide Blend
Cagrilintide + SM Blend is a novel synthetic peptide combination engineered for research on convergent metabolic signaling pathways. Cagrilintide is a long-acting DACRA (dual amylin and calcitonin receptor agonist) with demonstrated effects on appetite regulation, gastric emptying, and post-meal glucose control in laboratory models. SM is a GLP-1 receptor agonist studied for metabolic effects, insulin secretion, and glycemic control in research settings. Clinical research on amylin and incretin combination therapies demonstrates synergistic effects on metabolic regulation, weight reduction, glycemic control, and appetite suppression in laboratory and clinical models. Current phase 3 research programs are evaluating similar combination approaches for chronic weight management and metabolic health outcomes.
Each batch is independently HPLC verified for purity and concentration. QR-verified COAs. 5mg Cagrilintide + 5mg SM per vial.
⚠️ Research Use Only
Not for human consumption, veterinary use, or diagnostic applications. Purchasers must be 21+ and comply with all applicable regulations.
Product Name
Cagrilintide + SM Blend 10mg
CAS Number
1415456-99-3 (Cagrilintide) / 910463-68-2 (SM)
Molecular Formula
C₁₉₄H₃₁₂N₅₄O₅₉S₂ (Cagrilintide) / C₁₈₇H₂₉₁N₄₅O₅₉ (SM)
Form
Lyophilized Powder
Purity
99.52%
Storage
2-8°C (Refrigerate)
Shelf Life
24 months
Frequently Asked Questions
Everything researchers need to know
Reviews from Researchers
99%+ HPLC Purity
Every batch independently tested by a third-party US lab for verified purity.
QR-Verified COAs
Scan any Certificate of Analysis to see the original third-party test result instantly.
Next-Day Dispatch
Orders before 2 PM CST ship the next business day from Houston, TX.
Research Support
Our team understands peptide research. Contact us M-F, 10 AM-3 PM CST.
Related Products
